To examine the association between weight loss in obese pregnant women and relevant maternal and neonatal outcomes.
METHODS: All liveborn singleton term (37 weeks of gestation or greater) births in obese women between 2009 and 2011 in Flanders (the northern part of Belgium) were included (N518,053). Outcomes assessed included gestational hypertension, low (2,500 g or less) birth weight, small-for-gestational-age (less than the 10th percentile) neonates, macrosomia (birth weight 4,000 g or greater), large-for-gestational-age (greater than 90th percentile) neonates, emergency caesarean delivery, and admission to a neonatal intensive care unit. Risk for adverse outcomes was calculated by multiple logistic regression analysis for weight change categories (greater weight loss [5 kg or greater], lesser weight loss [between 0 and 5 kg], low gestational weight gain [0 or greater and less than 5 kg], adequate gestational weight gain [5 or greater to 9 kg or less, reference], and excessive gestational weight gain [greater than 9 kg]) in each obesity class (I 30-34.9, II 35-39.9, III 40 or greater) adjusted for parity and maternal and gestational age.
RESULTS:
In the total population, 854 (4.7%) obese pregnant women reported weight loss. Weight loss and low weight gain were associated with a decreased incidence of gestational hypertension for women with class I obesity (greater weight loss adjusted odds ratio [OR] 0.31, 95% confidence interval [CI] 0.11-0.84; lesser weight loss adjusted OR 0.46 95% CI 0.21-0.99; low gain adjusted OR 0.71 95% CI 0.54-0.93), a reduction in the rate of emergency cesarean delivery, but only in those with class II obesity (greater weight loss adjusted OR 0.24, 95% CI 0.07-0.78; lesser weight loss adjusted OR 0.50, 95% CI 0.26-0.97; low gain adjusted OR 0.55, 95% CI 0.38-0.79), and decreased macrosomia and large-for-gestational-age neonates in women in all classes of obesity, with the highest decrease for women with class III obesity (greater weight loss adjusted OR 0.15, 95% CI 0.05-0.49; lesser weight loss adjusted OR 0.37, 95% CI 0.15-0.90 for macrosomia). No association between weight loss and low birth weight, small-for-gestational-age neonates, or admission to the neonatal intensive care unit was shown in the different obesity classes.
CONCLUSION:
Weight loss in obese pregnant women was associated with reduced perinatal risks but not with the rate of low birth weight or small-forgestational-age neonates in obese women from class III in this affluent region. Stratification of recommended gestational weight gain ranges in obese women should be considered. 30 or greater) is a major public health concern because of the increased risks for both the mother and child. Obesity-associated risks include spontaneous abortion 1 and congenital malformations, 2 metabolic and cardiovascular dysfunctions presented as gestational diabetes 3 and hypertension, 4 and cesarean delivery. 5, 6 For the neonate, there is an increased risk of macrosomia and admission to a neonatal care unit. 7, 8 In the long term, children of obese mothers who were prone to metabolic dysfunctions in utero (fetal programming) may face further metabolic and cardiovascular problems as well as neurocognitive developmental problems. 9, 10 The Institute of Medicine (IOM) revised the gestational weight gain guidelines in 2009 and recommended that obese women should gain between 5 and 9 kg to obtain the best maternal and perinatal outcomes. 11 Emerging evidence suggests, however, that these recommendations are still too high and that even weight loss in pregnancy may have substantial benefits for both mother and child. Perinatal risks increase with increasing prepregnancy BMI and because we intended to examine the women with the highest risk in greater depth, we decided to study only obese pregnant women. We therefore examined the association between weight loss in obese women and risk for gestational hypertension, low (less than 2,500 g) birth weight and small-for-gestational-age (SGA) neonates, macrosomia (birth weight 4,000 g or greater) and large-for-gestational-age (LGA) neonates, emergency caesarean delivery, and admission to a neonatal intensive care unit (NICU).
MATERIALS AND METHODS
The Flemish Study Center for Perinatal Epidemiology has routinely registered perinatal data from all deliveries in Flanders since 1996. Perinatal data from all maternity units (n565) are collated centrally, subjected to an error detection program, and checked for accuracy and completeness through feedback with the individual maternity units and reassessment of patient records when required. In case of extreme values (considered outliers) or missing values, the maternity units are contacted for confirmation or correction. 12 All stillbirths or live births of neonates with a weight of 500 g or greater are included; the definitions used are in agreement with those from the World Health Organization and the Fédération Internationale de Gynécologie et d'Obstétrique. The Flemish Study Center for Perinatal Epidemiology database contains data about maternal and gestational age (completed weeks) at delivery, parity, gestational hypertension, gestational diabetes, mode of delivery, birth weight, sex, congenital malformations, admission to a NICU, and perinatal mortality and, from 2009, self-reported maternal height and weight before pregnancy and weight measured at delivery or at the last antenatal visit. 13 Data, including BMI and gestational weight gain, were available for 18,065 obese pregnant women who delivered singleton term live births between 2009 and 2011; 12 participants were excluded because of unreliable information on gestational weight change (weight loss more than 45 kg and gains of more than 60 kg). Ranges of maternal height (1.26-1.93 m), prepregnancy weight (53-170 kg), and weight at delivery (40-187 kg) were deemed acceptable. A total of 18,053 obese women were therefore included in the analysis.
The scientific committee of the Flemish Study Center for Perinatal Epidemiology granted approval for the analysis of the anonymized data. This study was exempt from approval by an institutional review board.
Body mass index was categorized according to the World Health Organization and the IOMmatched cutoffs. 11, 14 Obesity was defined as a BMI of 30 or greater and further categorized as obesity class I (BMI 30-34.9), class II (BMI 35-39.9), and class III (BMI 40 or greater). Gestational weight change was calculated by subtracting the maternal prepregnancy weight from the weight at delivery and was categorized as greater weight loss (5 kg or greater), lesser weight loss (between 0 and 5 kg), low gestational weight gain (0 or greater and less than 5 kg), normal gestational weight gain (5 or greater to 9 kg or less, in accordance with the 2009 IOM guidelines for obese women), and excessive gestational weight gain (greater than 9 kg). Similar weight change categories were used in other studies. 15, 16 Prepregnancy weight and height were self-reported during pregnancy. Maternal weight at delivery was measured in the delivery room or, if not available, the weight at the last prenatal visit was used.
We considered eight main outcomes of interest: gestational diabetes and gestational hypertension, emergency cesarean delivery, macrosomia (birth weight 4,000 g or greater), LGA (greater than 90th percentile), low birth weight (less than 2,500 g) SGA (less than the 10th percentile), and admission to a NICU. Small-and LGA neonates were defined by birth weights less than the 10th percentile or greater than 90th percentile, respectively, according to gestational age, sex, and parity-specific reference percentiles from our regional birth weight charts (Flemish Study Center for Perinatal Epidemiology, 2009). All of these outcomes were retrieved from the Study Center for Perinatal Epidemiology database.
In univariate analysis to assess the relation between the eight outcomes and categorical variables, likelihood ratio x 2 and Maentel-Haenszel x 2 were used. To assess the relation with continuous variables, t test and Mann-Whitney test were used. For the Unauthorized reproduction of this article is prohibited.
multivariate analyses, we only considered seven of the eight outcomes as we excluded patients with gestational diabetes (n51,109) as a result of the possible bias of diet interventions subsequent to the diagnosis of gestational diabetes in midpregnancy and the subsequent effect on the mother's weight change. Moreover, we did not have information about the weight gain at the time of diabetes diagnosis. For each of the seven outcomes, we built a logistic regression model to assess the association of gestational weight change with the outcome adjusting for parity, maternal age, and gestational age. The logistic regression models were performed twice: once with gestational weight change as a categorical variable and once as a continuous variable. For multiparous women with maternal age of 30 years and gestational age of 39 weeks, we calculated the predicted probability on an adverse outcome for each possible value of gestational weight change. Those predicted probabilities are presented graphically.
To adjust for multiple hypothesis testing, we applied the Bonferroni correction for the eight outcomes of interest, and we took into account the five categories of gestational weight gain (four comparisons); the statistical significance level becomes .05/(834)5.002.
All statistical analyses were performed with SAS 9.4.
RESULTS
In this cohort of obese pregnant women, 854 (4.7%) reported weight loss, 2,493 (13.8%) had a low weight gain (0-5 kg), 5,120 (28.3%) had an adequate gestational weight gain (5-9 kg), and 9,586 (53.1%) had gestational weight gain greater than 9 kg (excessive according to 2009 IOM guidelines). Within the obesity classes, 3.2% from class I lost weight during pregnancy compared with 7% from class II and 13.4% from class III. Increasing classes of obesity were associated with higher parity (P5.003) and lower gestational age at delivery (P,.001), whereas there was no difference in maternal age among the three classes (P5.31).
The prevalence of adverse perinatal outcomes significantly increased by increasing class of obesity, except for low birth weight (P5.51). The prevalence of SGA neonates decreased by increasing class of obesity (P5.04). In the univariate analysis, gestational hypertension, macrosomia, LGA neonates and emergency caesarean delivery decreased with decreasing categories of weight gain. The prevalence of gestational diabetes, low birth weight, and SGA neonates decreased with increasing categories of weight gain, whereas there was no difference for admission to a NICU (Table 1 ). In the total sample, 45.6% (n58,242) of obese women had at least one of the perinatal complications of interest. Of the 1,109 obese women who were excluded for gestational diabetes in the multivariate analysis, 47.3% (n5524) had gestational diabetes only, 19.2% (n5213) gestational diabetes and macrosomia or LGA neonates, and 9.2% (n5100) gestational diabetes and hypertension.
In the adjusted multivariate analysis, weight loss and low gestational weight gain were associated with a decreased adjusted odds ratio (OR) of gestational hypertension for women with class I obesity (greater weight loss adjusted OR 0.31, 95% confidence interval [CI] 0.11-0.84; lesser weight loss adjusted OR 0.46 95% CI 0.21-0.99; low gain adjusted OR 0.71 95% CI 0.54-0.93). Weight loss and low gain were also associated with a decreased adjusted OR of emergency caesarean deliveries, but only for women from class II (greater weight loss adjusted OR 0.24, 95% CI (Table 2 ).
In the multivariate analysis with weight change during pregnancy as a continuous variable, gestational weight gain was inversely related to low birth weight only for class I obese women (adjusted OR 0.97, 95% CI 0.95-0.99) and inversely related to SGA neonates for class I (adjusted OR 0.96, 95% CI 0.95-0.97) and class II (adjusted OR 0.97, 95% CI 0.95-0.98) obese women. Figure 1 shows the predicted probability of all the seven complications of interest, related to gestational weight gain, by class of obesity. The highest predicted probabilities are shown for macrosomia and LGA neonates. Figure 1 demonstrates that the predicted probabilities of macrosomia and LGA neonates are closely related in class I and II of obesity; in class III, the intercept of macrosomia is lower than for LGA neonates.
As shown in Figure 2 , the lowest predicted probability for SGA and LGA combined was associated with a weight gain of 0-5 kg in class I obesity, 0-5 kg weight loss in class II, and up to 15 kg weight loss in class III (additional material can be found as Appendix 1, available online at http://links.lww.com/ AOG/A606).
DISCUSSION
In this observational study, obese pregnant women who have a weight gain lower than recommended by the 2009 IOM guidelines have reduced risks of gestational hypertension, emergency caesarean delivery, macrosomia, and LGA neonates. Furthermore, those who lost weight (which was apparent in 5% of obese women) had a lower risk for gestational hypertension, emergency cesarean delivery, macrosomia, and LGA neonates, and this was not at the expense of an increase in low birth weight or SGA neonates.
Most studies cautiously recommend lower weight gains, no weight gain, or even weight loss for obese pregnant women to prevent adverse maternal outcomes. 6, [16] [17] [18] On the other hand, studies have until now demonstrated a positive association between weight loss and SGA neonates. 15, 16, 19, 20 The results of our study differ from the retrospective analysis of Catalano et al. 19 They included 1,241 singleton term overweight and obese pregnancies from two ongoing trials and concluded that weight loss or gain 5 kg or less was associated with more SGA neonates, lower birth weight, and lower fat and lean mass of the neonate compared with women with more than 5-kg weight gain. In their analysis, overweight and obese women were combined and only 46 of them had reported a weight loss. The mean weight gain in their weight loss and gain category was 1.1 kg (standard deviation [SD] 4.4) compared with 14.4 kg (SD 6.2) in their greater than 5-kg weight gain category. In our analysis, we included only obese women (n518,053) and reported a weight loss in 854 women. The mean weight loss (n5854) in our analysis was 5.96 kg (SD 5.99); mean weight gain (n517,199) was 10.76 kg (SD 6.06). Although Catalano et al 19 aimed to evaluate the association of inadequate gestational weight gain and fetal growth, they included overweight as well as extreme obese pregnant women, but these two groups may have different metabolic rates, which could affect the neonatal outcomes.
Previously, SGA has been associated with weight loss in women with class I and II but not class III obesity. 20, 21 Hinkle et al 21 showed that in class II and III women, a gestational weight gain from 24.9 kg to +4.9 kg (compared with those with gestational weight gain between 5 and 9 kg) did not significantly increase the odds of SGA and had the benefit of reducing macrosomia. Oza-Frank 22 showed an 11% increase in SGA for each kilogram of weight loss in obese women, but only in those from class I; no difference in SGA was demonstrated in obese women from classes II and III. When they compared obese women with weight gain less than 5 kg with those with adequate gestational weight gain (5-9 kg), no association with SGA was found between the obesity classes. Li et al 23 also demonstrated no difference in adjusted ORs for SGA and low birth weight if obese women had a weight gain less than 5 kg. These results match ours.
Thus, it appears that an increasing maternal BMI mitigates the effect of weight loss on fetal growth in terms of the probabilities of low birth weight and SGA neonates.
The prevalence of macrosomia has been increasing in our region over the past 15 years (Flemish Study Center for Perinatal Epidemiology, unpublished data) and has consequences for the child at short and long term. 10, 24 An estimated optimal gestational weight gain should be defined in relation to the lowest predicted risk of both low birth weight, SGA neonates and macrosomia, LGA neonates, because all of these risks are related to perinatal morbidity and mortality. 25, 26 The study of Beyerlein et al 27 suggested an optimal gestational weight gain range for obese women between 215 and +2 kg for a joint Unauthorized reproduction of this article is prohibited.
predicted risk of 20% or less of either SGA or LGA births. This range corresponds to our calculated weight gain for the lowest predicted probability of SGA and LGA neonates in the three different classes of obese women.
From a clinical point of view, our data show that obese women have better perinatal outcomes when they gain less than currently advised by the IOM, but this needs confirmation in prospective cohorts. Ideally, weight loss should be emphasized preconceptionally. Unauthorized reproduction of this article is prohibited.
On the other hand, taking part in healthy lifestyle coaching programs during pregnancy with a focus on healthy diet and stimulating physical activity can have benefits for both the mother and child. 28, 29 The strength in this analysis is the representativeness of this large regional cohort of obese pregnant women at term. We were therefore able to make a distinction among the various classes of weight change during pregnancy, including low weight gain (0-5 kg), lesser weight loss (between 0 and 5 kg) as well as greater weight loss (5 kg or greater). A gradual reduction in gestational hypertension, macrosomia, and LGA was associated with a decreasing category of weight change. We controlled for possible confounders such as maternal and gestational age and parity. A limitation in our study is that we did not control for maternal education, ethnicity, and smoking behavior because these data were not available, which can also influence some perinatal outcomes. However, in an earlier study, 13 we showed that obese women are more likely to be less educated, making them even more vulnerable for caesarean delivery and lower birth weight of term neonates. 12 Our data did not include information about the reasons for weight loss (eg, as a result of pregnancy complications or severe maternal illness or intentional weight loss). Further studies are underway to study the influence of weight loss on lean and fat mass in the fetus and neonate. 19, 30 Our analysis is restricted to full-term singleton live births, so these results may not be generalized to all pregnancies. Cause and effect cannot be determined by observational studies, so optimal gestational weight gain must be answered by performing a rigorous randomized controlled trial. A recent randomized trial of Dodd et al, 31 offering healthy eating and exercise advice to pregnant women who were overweight or obese, showed a significant reduction in the number of neonates with birth weights greater than 4 kg, with a number needed to treat of 28. Unfortunately, they did not reduce the risk of delivering a neonate weighing above the 90th centile. We are awaiting results from the UPBEAT 32 and DALI 33 trials to study effects of gestational weight gain on maternal and neonatal outcomes. When revising the gestational weight gain guidelines, long-term consequences of gestational weight gain (eg, chronic diseases such as hypertension, diabetes, and obesity) should be analyzed in light of mortality and morbidity.
